Emodin.

Polygonum cuspidatum root is a principal commercial source of emodin alongside its stilbenes. A formula carrying both delivers emodin twice, so total anthraquinone load should be read across them.

Emodin and resveratrol occur together in Japanese knotweed root, and many resveratrol extracts carry residual anthraquinone. They also share conjugation by the same glucuronidation and sulfation enzymes, so they compete for clearance capacity.

Whole-leaf aloe preparations carry hydroxyanthraquinones of the same class as emodin, which is why inner-gel material is specified when that activity is not wanted. Combining them raises the total anthraquinone content of a formula.

Emodin is cleared largely by glucuronidation, and piperine slows that same conjugation step. Co-dosing raises circulating unconjugated emodin rather than changing what emodin does.

Both are polyphenolic compounds handled by the same intestinal glucuronidation and sulfation enzymes. At high combined loads they compete for that finite conjugation capacity, which shifts the exposure of each.

Activated charcoal adsorbs planar aromatic molecules including anthraquinones, holding them in the gut lumen. Taken at the same time it lowers how much emodin is absorbed, so the two should be spaced apart.

Emodin arrives in plants largely as glucosides, and colonic bacterial beta-glucosidases release the free aglycone. The size and composition of that bacterial population therefore set how much active compound appears in the colon. Anything that shifts the microbiome shifts the conversion, in either direction.

Glycoside hydrolase activity varies by strain and determines how efficiently emodin glucoside is converted to the free form. This is a strain property, not a species property. The link is mechanistic; no combination study has been located.

Bifidobacteria carry glycoside hydrolases that act on plant glycosides in the colon, the same compartment where emodin glucoside is deconjugated. Their contribution is one part of a mixed community effort. Grounding is mechanistic.

Psyllium holds water and increases stool mass mechanically, while anthraquinones act on colonic secretion and motility signalling. Combined, the two act on regularity from separate directions, which is why they appear together in traditional bowel formulas. The additive direction is worth stating rather than assuming.

Poorly absorbed magnesium salts hold water in the lumen by osmosis, a mechanism entirely separate from anthraquinone signalling. In one product the two effects add up and can overshoot the intended result. Dose the combination with that additivity in mind.

Anthraquinone-driven increases in stool water carry potassium out with the fluid, and sustained use is the classic setting for potassium depletion. The relevant point for a formula is that potassium status deserves attention rather than that potassium should be added reflexively. This is established pharmacology of the anthraquinone class.

Any agent that raises stool water raises obligate electrolyte and fluid loss with it. Replacing that loss is ordinary supportive practice rather than a synergy in the promotional sense. State it as a handling note.

Slippery elm forms a viscous mucilage layer traditionally combined with stimulant botanicals in bowel formulas. The mucilage may also slow contact between the anthraquinone and the mucosa. The pairing rests on traditional formulation practice.

Marshmallow root mucilage is used alongside stimulant bowel herbs in traditional formulas for its coating properties. It changes the physical environment the anthraquinone acts in rather than the anthraquinone itself. The basis is traditional practice.

Animal work reports that emodin's effect on the liver depends on the metabolic environment, with opposite directions under different conditions. Silymarin is conventionally added to formulas containing hepatically handled botanicals. The pairing is conventional and mechanistically plausible rather than measured together.

Quinones including anthraquinones form conjugates with glutathione as part of their disposal, drawing on cysteine supply. N-acetylcysteine feeds that pool. The relationship is established quinone biochemistry rather than a studied supplement combination.

Glutathione conjugates reactive quinone species, which is one of the main disposal routes for anthraquinone metabolites. Cell studies of emodin routinely report changes in glutathione status alongside reactive oxygen species measures. Those are markers in cells, not outcomes in people.

Emodin behaves as a redox-cycling quinone in cell systems, generating reactive oxygen species in some conditions and reducing markers of oxidative stress in others. Alpha-lipoic acid participates in the same redox network. The interaction is in vitro chemistry and its direction in people is not established.

Ascorbate reduces quinones to semiquinones and hydroquinones in vitro, which can either dampen or accelerate redox cycling depending on conditions and on transition metal availability. Because the direction is condition dependent, this is a note rather than a recommendation. Bench chemistry only.

The peri-hydroxy arrangement on emodin coordinates iron, which is a documented property of hydroxyanthraquinones. Chelated iron is absorbed less well, and iron-bound quinones also behave differently in redox chemistry. Both directions are reasons to keep the doses apart.

Emodin-containing rhubarb and berberine-containing sources appear together in traditional Chinese formulations. Both are extensively metabolised and both are substrates for efflux transporters in the gut wall. Any pharmacokinetic interaction is inferred from that shared handling, not measured.

Curcumin and emodin are both conjugated heavily by UGT enzymes in the intestinal wall, which is the main brake on their systemic exposure. Competition for that capacity can raise the unconjugated fraction of either. The mechanism is established for the class; the specific pair has not been measured.

EGCG inhibits several conjugating enzymes at concentrations reachable in the gut lumen, and emodin depends on those same enzymes for its first-pass handling. A stack could raise emodin exposure. This is class-level pharmacology, not a studied combination.

Bentonite binds a wide range of small organic molecules by surface adsorption and cation exchange, anthraquinones included. Taken in the same window it lowers how much emodin is available in the lumen. Space the doses if both are in a regimen.